CClinicalTrials.gg
Active, not recruitingNCT06309342PREVFUNKTIONUpdated Sep 9, 2026

Prevention of Lifestyle-related Disorders Based on Functional Examinations

An interventional study of PREVFUNKTION and Control in Lifestyle-related Condition, sponsored by Lena Bornhoft. Active, not recruiting at 2 sites in Sweden. Open to participants aged 39 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Lena Bornhoft · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
39 Years to 40 Years
Sex
All
01

Study summary

The goal of this randomised controlled trial is to examine the effects of functional examinations and feedback/support on healthy 40-year-olds. The main questions it aims to answer are: • Does feedback and motivational interviewing after testing physical function motivate inactive middle-aged people to increase their physical activity level? • Does the intervention lead to health benefits over time - less pain, better function, higher health-related quality of life, fewer risk factors for lifestyle-related illness? Participants will: • undergo medical and functional health examinations, • their physical activity level will be measured, • receive feedback and advice based on both parts of the examinations, • receive a functional profile, • be supported in goalsetting for lifestyle changes. Researchers will compare with a control group who, after the examinations, receive feedback only from the medical examination to see if participants become more physically active, achieve better function, become more motivated to make lifestyle changes, reduce risk factors for lifestyle-related illness, achieve health benefits and better health-related quality of life.

Read the detailed description

Relatively healthy 40-year-olds will be examined at baseline and 1 year with both standard medical and newly developed functional examinations and physical activity level will be measured with accelerometers. The intervention group will receive feedback on all their results. A functional profile will be compiled and explained to each participant and they will receive support in setting relevant goals for lifestyle changes and making realistic plans to achieve them. The control group will also be examined as above but will receive feedback and advice based only on the standard medical examination.

02

Conditions studied

  • Lifestyle-related Condition

Keywords

  • Lifestyle
  • Prevention
  • Physical activity
  • Fitness
  • Health examination
03

In context

Mental Disorders

2,107 studies on the registry are indexed under Mental Disorders; 416 are open to participants now.

This study's planned enrollment of 250 is above the median of 94 across 1,574 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Lena Bornhoft is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
39 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 40 years of age
  • Relatively normal general mobility - can walk without support and have no self-reported difficulties with using all four extremities - in order to be able to perform standardised functional performance tests.
  • Self-assessed as physically inactive (level 1 or 2 on the Saltin Grimby Physical Activity Level Scale) as inactive people stand to gain most from this intervention.

Exclusion criteria

Exclusion Criteria:

  • Verbally self-reported physical activity at level three or four on Saltin Grimby Physical Activity Level Scale.
  • Severe mental illness or intellectual impairment, as participants will be expected to fill out questionnaires and should have the ability to follow healthcare advice independently should they choose to do so.
  • Pregnancy and/or on-going treatment requiring hospital-based services, to increase probability of baseline values which reflect usual capacity.
  • No language restrictions are planned but participants needing interpreter help should arrange this themselves.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
250 participants (estimated)

Study arms

  • Experimental
    PREVFUNKTION

    Medical examination. Functional examination. Measurement of physical activity. Questionnaires on health, function and lifestyle. Feedback and advice based on medical examination. Feedback and advice based on functional examination. Functional profile. Support in setting goals for lifestyle changes.

    Other: PREVFUNKTION · Other: Control

  • Active comparator
    Control

    Medical examination. Functional examination. Measurement of physical activity. Questionnaires on health, function and lifestyle. Feedback and advice based on medical examination.

    Other: Control

Interventions

  • OtherPREVFUNKTION

    Functional profile and advice concerning cardiovascular fitness level, strength, mobility, balance and posture. Motivational interview and support in goalsetting to make lifestyle changes.

  • OtherControl

    Physical activity measured with accelerometers. Functional examination. Medical examination and advice concerning weight measures, blood pressure and standard blood tests.

06

What researchers measure

Primary outcomes

  1. Change in objectively measured physical activity

    Mean daily minutes in moderate-to-very vigorous physical activity measured with accelerometers for 1 week

    Time frame: Change between baseline and 1-year follow-up

  2. Change in objectively measured sedentary behaviour

    Mean daily minutes of sedentary behaviour measured with accelerometers for 1 week

    Time frame: Change between baseline and 1-year follow-up

Secondary outcomes

  1. Change in cardiovascular fitness

    Fitness level measured in ml/kg/min using the Ekblom Bak submaximal ergometer test

    Time frame: Change between baseline and 1-year follow-up

  2. Change in motivation level

    Motivation to make lifestyle changes to improve health on an 11-point numerical rating scale.

    Time frame: Change between baseline and 1-year follow-up

  3. Proportion achieved goals

    Proportion of goals achieved of the goals set by the intervention group at baseline

    Time frame: Measured only at 1-year follow-up

  4. Change in fitness level

    Point level on the study-specific functional profile arm for fitness where points are given for grade of deviation from norm. Minimum -2, maximum +2. Higher scores indicate better fitness level.

    Time frame: Change between baseline and 1-year follow-up

  5. Change in strength upper extremity

    Point level on the study-specific functional profile arm for strength upper extremity where points are given for grade of deviation from norm. Minimum -2, maximum +2. Higher scores indicate better strength.

    Time frame: Change between baseline and 1-year follow-up

  6. Change in strength lower extremity

    Point level on the study-specific functional profile arm for strength lower extremity where points are given for grade of deviation from norm. Minimum -2, maximum +2. Higher scores indicate better strength.

    Time frame: Change between baseline and 1-year follow-up

  7. Change in strength trunk muscles

    Point level on the study-specific functional profile arm for strength trunk where points are given for grade of deviation from norm. Minimum -2, maximum +2. Higher scores indicate better strength.

    Time frame: Change between baseline and 1-year follow-up

  8. Change in balance

    Point level on the study-specific functional profile arm for balance where points are given for grade of deviation from norm. Minimum -2, maximum +2. Higher scores indicate better balance.

    Time frame: Change between baseline and 1-year follow-up

  9. Change in mobility

    Point level on the study-specific functional profile arm for mobility where points are given for grade of deviation from norm. Minimum -2, maximum 0. Lower score indicates mobility dysfunction, 0 indicates normal mobility.

    Time frame: Change between baseline and 1-year follow-up

  10. Change in posture

    Point level on the study-specific functional profile arm for posture where points are given for grade of deviation from norm. Minimum -1, maximum 0. Lower score indicates postural deviations, 0 indicates normal postural measurements.

    Time frame: Change between baseline and 1-year follow-up

  11. Change in weight measures

    Point level on the study-specific functional profile arm for weight where points are given for grade of deviation from recommended values. Minimum -2, maximum 0. Lower score indicates overweight (or underweight), 0 indicates normal weight.

    Time frame: Change between baseline and 1-year follow-up

  12. Change in pain

    Point level on the study-specific functional profile arm for pain where points are given for number of pain locations, score on the Örebro Musculoskeletal Pain Screening Questionnaire and on the pain question on Euroqol-5 dimensions-3 levels. Minimum -2, maximum 0. Lower score indicates more pain, 0 indicates no pain.

    Time frame: Change between baseline and 1-year follow-up

  13. Change in physical activity

    Point level on the study-specific functional profile arm for physical activity where points are given for grade of deviation from recommended values when objectively measured with accelerometers. Minimum -2, maximum +2. Increased point value indicates higher physical activity level.

    Time frame: Change between baseline and 1-year follow-up

  14. Change in handgrip strength

    Measured with Jamar handdynamometer (kg)

    Time frame: Change between baseline and 1-year follow-up

  15. Change in biceps strength

    Measured with 30-second biceps test (number repetitions)

    Time frame: Change between baseline and 1-year follow-up

  16. Change in leg strength

    Measured with 30-second chair-stand test (number repetitions)

    Time frame: Change between baseline and 1-year follow-up

  17. Change in calf strength

    Measured with single-foot heel rises (number repetitions)

    Time frame: Change between baseline and 1-year follow-up

  18. Change in ventral trunk strength

    Measured with plank test (seconds)

    Time frame: Change between baseline and 1-year follow-up

  19. Change in dorsal trunk strength

    Measured with back endurance test (seconds)

    Time frame: Change between baseline and 1-year follow-up

  20. Change in lower trunk strength

    Measured with supine bridge test (seconds)

    Time frame: Change between baseline and 1-year follow-up

  21. Change in static balance - 1

    Measured with stand-on-one-leg-eyes-open test (seconds)

    Time frame: Change between baseline and 1-year follow-up

  22. Change in static balance - 2

    Measured with stand-on-one-leg-eyes-closed test (seconds)

    Time frame: Change between baseline and 1-year follow-up

  23. Change in static balance - 3

    Measured with sharpened Romberg test (seconds)

    Time frame: Change between baseline and 1-year follow-up

  24. Change in dynamic balance

    Measured with functional reach test (centimeters)

    Time frame: Change between baseline and 1-year follow-up

  25. Change in mobility - 1

    Measured with sit-rise test (points)

    Time frame: Change between baseline and 1-year follow-up

  26. Change in mobility - 2

    Measured with finger-floor test (centimeters)

    Time frame: Change between baseline and 1-year follow-up

  27. Change in mobility - 3

    Measured with lateral flexion test (centimeters)

    Time frame: Change between baseline and 1-year follow-up

  28. Change in hypermobility score

    Measured with Beighton hypermobility score with point values between 0 and 9 where score over 4 indicate general hypermobility.

    Time frame: Change between baseline and 1-year follow-up

  29. Change in neck mobility

    Measured with occiput-to-wall test (points)

    Time frame: Change between baseline and 1-year follow-up

  30. Change in foot pronation

    Measured with navicular drop test (millimeters)

    Time frame: Change between baseline and 1-year follow-up

  31. Change in habitual stance

    Measured with patella mobility test (points)

    Time frame: Change between baseline and 1-year follow-up

  32. Change in health-related quality of life assessed with EQ5D index

    Measured with index values for Euroqol-5 dimensions-3 levels. Minimum -0.59, maximum +1. Higher scores indicate better health-related quality of life.

    Time frame: Change between baseline and 1-year follow-up

  33. Change in health-related quality of life assessed with EQ5D VAS

    Measured with the 100-point barometer for Euroqol-5 dimensions-3 levels. Minimum 0, maximum 100. Higher scores indicate better health-related quality of life.

    Time frame: Change between baseline and 1-year follow-up

  34. Change in self-reported physical activity assessed with Swedish questionnaire

    Measured with Swedish National Board of Health and Welfare questionnaire with 2 questions on physical activity and exercise measured in minutes. Minimum 0, maximum measured value 540. Increasing values indicate higher levels of physical activity.

    Time frame: Change between baseline and 1-year follow-up

  35. Change in self-reported physical activity assessed with Saltin Grimby Physical Activity Level Scale (SGPALS)

    Measured with SGPALS with point values between 1 and 4 where increasing values indicate higher level of physical activity.

    Time frame: Change between baseline and 1-year follow-up

  36. Change in self-reported sedentary time

    Measured in hours per day with SED-GIH questionnaire with values between 0 and 24 where increasing sedentary time is considered to have a negative impact on health.

    Time frame: Change between baseline and 1-year follow-up

  37. Change in risk for chronic pain and sickness absence assessed with Örebro Musculoskeletal Pain Screening Questionnaire

    Measured with Örebro Musculoskeletal Pain Screening Questionnaire with scores between 1 and 100 where increasing values indicate higher risk for chronic pain and sickness absence.

    Time frame: Change between baseline and 1-year follow-up

  38. Change in number of pain locations

    Measured with a pain diagram

    Time frame: Change between baseline and 1-year follow-up

  39. Change in proportion smokers

    Proportion smokers in each group

    Time frame: Change between baseline and 1-year follow-up

  40. Change in proportion acceptable level blood glucose

    Proportion with blood glucose levels within recommended limits (4.0-6.0 mmol/L)

    Time frame: Change between baseline and 1-year follow-up

  41. Change in proportion acceptable level serum cholesterol

    Proportion with cholesterol levels within recommended limits (3.3-6.9 mmol/L)

    Time frame: Change between baseline and 1-year follow-up

  42. Change in proportion acceptable level triglycerides

    Proportion with triglyceride levels within recommended limits (0,45-2.6)

    Time frame: Change between baseline and 1-year follow-up

  43. Change in proportion acceptable blood pressure

    Proportion of participants with blood pressure within recommended limits

    Time frame: Change between baseline and 1-year follow-up

  44. Change in proportion normal body mass index (BMI)

    Proportion of participants with BMI within recommended limits

    Time frame: Change between baseline and 1-year follow-up

  45. Change in proportion acceptable waist circumference

    Proportion of participants with waist circumference below recommended level

    Time frame: Change between baseline and 1-year follow-up

  46. Change in stress symptoms assessed with Stress and Crisis Inventory-93

    Measured with Stress and Crisis Inventory-93 questionnaire. Minimum 0, maximum 140, with higher values indicating higher stress levels.

    Time frame: Change between baseline and 1-year follow-up

  47. Change in depression and anxiety symptoms assessed with Hospital Anxiety and Depression Scale

    Measured with Hospital Anxiety and Depression Scale. Minimum 0, maximum 42 with 21 as maximum for anxiety and 21 maximum for depression. Increasing values indicate more severe symptoms.

    Time frame: Change between baseline and 1-year follow-up

  48. Correlation between self-assessed and objectively measured fitness

    Correlation between fitness self-assessed on a 5-point Likert scale and point value on the fitness arm on the study-specific functional profile. Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Time frame: Change between baseline and 1-year follow-up

  49. Correlation between self-assessed and objectively measured fitness - 2

    Correlation between fitness self-assessed on a 5-point Likert scale and fitness grade on the Ekblom Bak fitness test (5 point Likert scale). Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Time frame: Change between baseline and 1-year follow-up

  50. Correlation between self-assessed and objectively measured strength upper extremity

    Correlation between upper extremity strength self-assessed on a 5-point Likert scale and point value for the strength upper extremity arm on the study-specific functional profile. Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Time frame: Change between baseline and 1-year follow-up

  51. Correlation between self-assessed and objectively measured strength lower extremity

    Correlation between lower extremity strength self-assessed on a 5-point Likert scale and point value for the strength lower extremity arm on the study-specific functional profile. Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Time frame: Change between baseline and 1-year follow-up

  52. Correlation between self-assessed and objectively measured balance

    Correlation between balance self-assessed on a 5-point Likert scale and point value on the balance arm on the study-specific functional profile. Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Time frame: Change between baseline and 1-year follow-up

  53. Correlation between self-assessed and objectively measured physical activity

    Correlation between self-assessed walking ability on a 5-point Likert scale and point value on the physical activity arm on the study-specific functional profile. Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Time frame: Change between baseline and 1-year follow-up

  54. Correlation between self-assessed and objectively measured physical activity - 2

    Correlation between self-assessed walking ability on a 5-point Likert scale and number of daily minutes in moderate-to-very vigorous physical activity measured with accelerometers. Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Time frame: Change between baseline and 1-year follow-up

  55. Change in relative physical activity

    Mean daily minutes of moderate-to-very vigorous physical activity measured with accelerometers for 1 week where moderate is individually calculated in relation to fitness level (46% of VO2max).

    Time frame: Change between baseline and 1-year follow-up

  56. Change in sufficient physical activity

    Number of mean daily minutes of physical activity measured with accelerometers for 1 week above a known health-promoting level based on a fitness level of 31.5 ml/kg for women and 35 ml/kg for men.

    Time frame: Change between baseline and 1-year follow-up

07

Study locations

2 sites
  • Familjeläkarna i Mölnlycke
    Mölnlycke, Region Västra Götaland 43544, Sweden
  • Capio Vårdcentral/Rehab Kvillebäcken
    Gothenburg, Sweden
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06309342
Lead sponsor
Lena Bornhoft
Collaborators
Vastra Gotaland Region, Göteborg University
Responsible party
Lena Bornhoft (Research and development leader, Göteborg University) — Sponsor-investigator
First posted
Mar 13, 2024
Start date
Aug 28, 2024
Primary completion
Jan 2027 (estimated)
Completion
Jan 2027 (estimated)
Last update
Sep 9, 2026

Study contacts

Lena Bornhöft, PhD
principal investigator · Region Västra Götaland, University of Gothenburg

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion